The phosphatase domains of LAR, CD45, and PTP1B: structural correlations with peptide-based inhibitors

被引:11
作者
Glover, NR
Tracey, AS [1 ]
机构
[1] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada
[2] Simon Fraser Univ, Inst Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada
关键词
protein tyrosine phosphatase; PTP; PTP1B; CD45; LAR; homology modeling;
D O I
10.1139/bcb-78-1-39
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
PTP1B is a cytosolic protein tyrosine phosphatase that is a regulator of the kinase activity of the insulin receptor; the two protein tyrosine phosphatases LAR and CD45 are receptor type phosphatases crucially important to cell function. LAR also is involved in regulation of the insulin receptor while CD45 is critical for T-cell activation. Although LAR and CD45 are both transmembrane phosphatases, these enzymes manifest their phosphatase activity through a catalytic cytosolic domain. We have utilized X-ray coordinates of related phosphatases (RPTP alpha and RPTP mu) and comparative protein modeling to obtain molecular models of the D1 catalytic domains of CD45 and LAR. The models were tested using established protocols and found to be comparable to low resolution X-ray structures. The structure obtained for LAR was compared with the recently reported X-ray structure. Both the CD45-D1 and LAR-D1 structures were then compared to and contrasted with PTP1B. The active site of pockets of the three enzymes were found to be very uniform in structure and charge distribution. Also, the gross surface topology around the active site was found to be somewhat similar for the 3 phosphatases. However, there were significant differences in surface topology, and, more importantly, large changes in surface charge distribution. The differences between the surface features of these enzymes provide an explanation for the selectivity of inhibition by a number of peptides.
引用
收藏
页码:39 / 50
页数:12
相关论文
共 55 条
[1]  
Ahmad F, 1997, J BIOL CHEM, V272, P448
[2]  
ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
[3]  
Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28
[4]   The SWISS-PROT protein sequence data bank and its new supplement TREMBL [J].
Bairoch, A ;
Apweiler, R .
NUCLEIC ACIDS RESEARCH, 1996, 24 (01) :21-25
[5]   Protein-tyrosine phosphatase 1B complexes with the insulin receptor in vivo and is tyrosine-phosphorylated in the presence of insulin [J].
Bandyopadhyay, D ;
Kusari, A ;
Kenner, KA ;
Liu, F ;
Chernoff, J ;
Gustafson, TA ;
Kusari, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (03) :1639-1645
[6]   Protein phosphatases [J].
Barford, D .
CURRENT OPINION IN STRUCTURAL BIOLOGY, 1995, 5 (06) :728-734
[7]   CRYSTAL-STRUCTURE OF HUMAN PROTEIN-TYROSINE-PHOSPHATASE 1B [J].
BARFORD, D ;
FLINT, AJ ;
TONKS, NK .
SCIENCE, 1994, 263 (5152) :1397-1404
[8]  
BARTON GJ, 1996, PROTEIN STRUCTURE PR, P31
[9]   Structural basis for inhibition of receptor protein-tyrosine phosphatase-alpha by dimerization [J].
Bilwes, AM ;
denHertog, J ;
Hunter, T ;
Noel, JP .
NATURE, 1996, 382 (6591) :555-559
[10]  
*BIOS MSI, 1995, INS MOL MOD SYST COM